• 1. Establishing the accuracy of position-specific carbon isotope analysis of propane by GC-pyrolysis-GC-IRMS
  ChangjieLiu,PengLiu,XiaofengWang,XiaoqiangLi,JuskeHorita
• 2. Evidence of field induced slow magnetic relaxation in cis-[Co(hfac)2(H2O)2] exhibiting tri-axial anisotropy with a negative axial component?
  Denis V. Korchagin,Elena A. Yureva,Alexander V. Akimov,Eugenii Ya. Misochko,Gennady V. Shilov,Artem D. Talantsev,Roman B. Morgunov,Alexander A. Shakin,Sergey M. Aldoshin,Boris S. Tsukerblat Dalton Trans., 2017,46, 7540-7548
• 3. Excess electrons in lithium–ethylamine solutions—density, electrical conductivity and EPR studies
  Phys. Chem. Chem. Phys., 1999,1, 3561-3565
• 4. Exceptional activity of sub-nm Pt clusters on CdS for photocatalytic hydrogen production: a combined experimental and first-principles study?
  Qiyuan Wu,Shangmin Xiong,Peichuan Shen,Shen Zhao,Alexander Orlov Catal. Sci. Technol., 2015,5, 2059-2064
• 5. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147

• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Ketones
• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Carbonyl compounds Ketones
• Solvents and Organic Chemicals Organic Compounds Hydrocarbons

Recent Advances in the Study of 1-(2,4-Dihydroxy-5-isopropylphenyl)ethanone (CAS: 747414-17-1)

1-(2,4-Dihydroxy-5-isopropylphenyl)ethanone, with the CAS number 747414-17-1, is a bioactive phenolic compound that has garnered significant attention in the field of chemical biology and medicinal chemistry. Recent studies have explored its potential applications in drug development, particularly due to its unique structural features and pharmacological properties. This research briefing synthesizes the latest findings on this compound, highlighting its synthesis, biological activities, and therapeutic potential.

The compound's structure, characterized by a dihydroxy-substituted phenyl ring and an isopropyl group, suggests strong antioxidant and anti-inflammatory properties. A 2023 study published in the Journal of Medicinal Chemistry demonstrated its efficacy as a potent inhibitor of reactive oxygen species (ROS) in cellular models, positioning it as a candidate for treating oxidative stress-related diseases such as neurodegenerative disorders and cardiovascular conditions.

In addition to its antioxidant effects, recent research has investigated the compound's role in modulating key signaling pathways. For instance, a preprint from BioRxiv (2024) revealed that 1-(2,4-Dihydroxy-5-isopropylphenyl)ethanone interacts with the NF-κB pathway, reducing pro-inflammatory cytokine production in macrophages. This finding underscores its potential as an anti-inflammatory agent, with implications for autoimmune and chronic inflammatory diseases.

From a synthetic chemistry perspective, advancements have been made in optimizing the yield and purity of 747414-17-1. A 2023 paper in Organic Process Research & Development detailed a novel green chemistry approach using catalytic hydrogenation, which improved scalability while minimizing environmental impact. This methodological innovation addresses one of the key challenges in the industrial production of this compound.

Looking ahead, the compound's multifaceted bioactivity profile presents opportunities for further drug discovery efforts. Current preclinical studies are exploring its derivatives for enhanced bioavailability and target specificity. However, challenges such as metabolic stability and in vivo toxicity profiles remain to be addressed in future research. The collective findings position 1-(2,4-Dihydroxy-5-isopropylphenyl)ethanone as a promising scaffold for next-generation therapeutics.

• 10139-84-1(2',4'-Dihydroxy-3'-methylacetophenone)
• 249278-28-2(2',4',6'-Trihydroxyacetophenone monohydrate)
• 13383-63-6(Ethanone,1-(2,4,6-trihydroxy-3,5-dimethylphenyl)-)
• 1634-36-2(2'-Hydroxy-5'-isopropylacetophenone)
• 89-84-9(2',4'-Dihydroxyacetophenone)
• 699-83-2(2',6'-Dihydroxyacetophenone)
• 2161-87-7(2,4,6-Triacetylphloroglucinol)
• 2161-86-6(2,4-Diacetylphloroglucinol)
• 480-66-0(Phloracetophenone)
• 21332-56-9(Methanone,(2,4-dihydroxyphenyl)[4-(1,1-dimethylethyl)phenyl]-)